4//SEC Filing
Novara Mark David 4
Accession 0001438133-25-000089
CIK 0001438133other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 6:06 PM ET
Size
10.6 KB
Accession
0001438133-25-000089
Insider Transaction Report
Form 4
Novara Mark David
EVP & CHIEF COMMERCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-05-15+304→ 25,308 total - Exercise/Conversion
Restricted Stock Unit
2025-05-15−304→ 609 total→ Common Stock (304 underlying) - Award
Common Stock
2025-05-15$19.30/sh+870$16,791→ 25,004 total - Tax Payment
Common Stock
2025-05-15$22.70/sh−113$2,565→ 25,195 total
Footnotes (5)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2024, through May 15, 2025. This transaction is also exempt under Rule 16b-3(c).
- [F2]Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- [F3]Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F4]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F5]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Documents
Issuer
TANDEM DIABETES CARE INC
CIK 0001438133
Entity typeother
Related Parties
1- filerCIK 0002000342
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 6:06 PM ET
- Size
- 10.6 KB